Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study

Changes in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating dapagliflozin therapy: a primary care database study

Markus F Scheerer,1 Roland Rist,1 Orm Proske,1 Annika Meng,2 Karel Kostev2 1Medical Department, AstraZeneca GmbH, Wedel, Germany; 2IMS Health GmbH & Co. OHG, Frankfurt am Main, Germany Aims: To investigate changes in glycated hemoglobin (HbA1c), body weight (BW), and systolic blood pressure...

Full description

Bibliographic Details
Main Authors: Scheerer MF, Rist R, Proske O, Meng A, Kostev K
Format: Article
Language:English
Published: Dove Medical Press 2016-10-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
type 2 diabetes
dapagliflozin
HbA1c
body mass index
systolic blood pressure
Online Access:https://www.dovepress.com/changes-in-hba1c-body-weight-and-systolic-blood-pressure-in-type-2-dia-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/changes-in-hba1c-body-weight-and-systolic-blood-pressure-in-type-2-dia-peer-reviewed-article-DMSO

Similar Items